| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2019 | LNTH Lantheus Holdings, Inc. | Leno Sam R | Director | Sell | 11,508 | $20.30 | $233,554.86 | -23.2% | |
| Dec 13, 2019 | JNJ Johnson & Johnson | Joly Hubert | Director | Buy | 5,000 | $141.28 | $706,399.00 | New | |
| Dec 12, 2019 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 166,667 | $0.90 | $150,000.30 | +31.6% | |
| Dec 12, 2019 | JNJ Johnson & Johnson | Wengel Kathryn E61 | EVP, Chief Gsc Officer | Sell | 2,017 | $141.07 | $284,538.19 | -3.9% | |
| Dec 12, 2019 | EBS Emergent Biosolutions Inc. | Bailey Sue | Director | Sell | 8,375 | $53.46 | $447,727.50 | -15.3% | |
| Dec 12, 2019 | AVDL Avadel Pharmaceuticals Plc | Hatten Sandra L | See Remarks | Sell | 3,072 | $7.23 | $22,210.56 | -5.2% | |
| Dec 11, 2019 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 100,000 | $18.30 | $1,829,540.00 | -39.5% | |
| Dec 11, 2019 | CVSI Cv Sciences, Inc. | Maroon Joseph C Md | Director | Buy | 71,725 | $1.05 | $75,430.25 | +5.5% | |
| Dec 9, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 10,962 | $119.70 | $1,312,151.40 | - | |
| Dec 9, 2019 | SIGA Siga Technologies Inc | Savas Paul G | Director | Buy | 20,000 | $4.37 | $87,400.00 | +7.3% | |
| Dec 9, 2019 | SIGA Siga Technologies Inc | Kane Julie | Director | Buy | 2,500 | $4.39 | $10,975.00 | New | |
| Dec 9, 2019 | SIGA Siga Technologies Inc | Luckshire Daniel J | Executive VP &CFO | Buy | 5,000 | $4.39 | $21,950.00 | +2.3% | |
| Dec 9, 2019 | SIGA Siga Technologies Inc | Gomez Phillip Louis III | Chief Executive Officer | Buy | 10,000 | $4.42 | $44,200.00 | +2.1% | |
| Dec 6, 2019 | LLY Eli Lilly & Co | O'Neill Myles | SVP &Pres., Mfg. Operations | Sell | 25,000 | $120.00 | $3,000,000.00 | -42.8% | |
| Dec 6, 2019 | LLY Eli Lilly & Co | Zulueta Alfonso G | SVP &President, Lilly Int'l | Sell | 4,500 | $120.00 | $540,000.00 | -13.3% | |
| Dec 6, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 194,038 | $120.15 | $23,313,498.42 | - | |
| Dec 5, 2019 | BMY Bristol Myers Squibb Co | Dubow Adam63 | Chief Compliance &Ethics Offi | Sell | 1,740 | $58.81 | $102,329.40 | -9.9% | |
| Dec 4, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 1,000 | $4.79 | $4,790.00 | -100% | |
| Dec 4, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $118.52 | $24,890,040.00 | -0.2% | |
| Dec 4, 2019 | BMY Bristol Myers Squibb Co | Bonney Michael W | Director | Buy | 88 | $58.90 | $5,183.20 | +1.2% | |
| Dec 4, 2019 | AVDL Avadel Pharmaceuticals Plc | Ende Eric J81 | Director | Buy | 10,000 | $5.97 | $59,700.00 | +26.4% | |
| Dec 3, 2019 | AVDL Avadel Pharmaceuticals Plc | Palczuk Linda78 | Director | Buy | 7,500 | $5.91 | $44,325.00 | +26.9% | |
| Dec 3, 2019 | ZTS Zoetis Inc. | David Glenn | Chief Financial Officer | Sell | 21,301 | $120.14 | $2,559,075.17 | -46.4% | |
| Dec 2, 2019 | NBIX Neurocrine Biosciences Inc | Abernethy Matt57 | Chief Financial Officer | Sell | 1,645 | $116.33 | $191,360.38 | -29.8% | |
| Dec 2, 2019 | PCRX Pacira Biosciences, Inc. | Longenecker John P Phd | Director | Sell | 1,300 | $46.13 | $59,971.60 | -9.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.